| Literature DB >> 32014680 |
Samo Guzelj1, Martina Gobec1, Dunja Urbančič1, Irena Mlinarič-Raščan1, Emanuela Corsini2, Žiga Jakopin3.
Abstract
NOD1 and NOD2 are pattern recognition receptors that have important roles in innate immune responses. Although their overactivation has been linked to a number of diseases, NOD2 in particular remains a virtually unexploited target in this respect, with only one structural class of antagonist reported. To gain insight into the structure-activity relationships of NOD2 antagonists, a series of novel analogs was designed and synthesized, and then screened for antagonist activity versus NOD2, and counter-screened versus NOD1. Compounds 32 and 38 were identified as potent and moderately selective NOD2 antagonists, and 33 and 42 as dual NOD1/NOD2 antagonists, with balanced activities against both targets in the low micromolar range. These data enable in-depth exploration of their structure-activity relationships and provide deeper understanding of the structural features required for NOD2 antagonism.Entities:
Keywords: Immunomodulation; Interleukin-8; NF-κB activation; NOD1 antagonist; NOD2 antagonist; Tumor necrosis factor-α
Year: 2020 PMID: 32014680 DOI: 10.1016/j.ejmech.2020.112089
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514